Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Flamel raises $25 million in initial public offering (IPO):

This article was originally published in Clinica

Executive Summary

French drug delivery and biomaterials company Flamel Technologies raised over $25 million in an IPO on the Nasdaq at the end of June, increasing its cash and cash equivalents to $29.2 million. Flamel reported revenues of $3 million in the first six months of 1996, compared with $1.2 million in the same period a year ago. Half-year net loss was $3.9 million, up from $2.8 million in the first six months of 1995. Revenues in 1996 reflect the first quarter payment of $1.5 million received from GD Searle as a non-recurring licence fee, says Flamel.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT088733

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel